Liraglutide reduces coronary endothelial cells no-reflow damage through activating MAPK/ERK signaling pathway

References

• Zhang L, Tian J, Diao S, et al. GLP-1 receptor agonist liraglutide protects cardiomyocytes from IL-1beta-induced metabolic disturbance and mitochondrial dysfunction. Chem Biol Interact. 2020;9:e109252.
   Web of Science ®Google Scholar
• Almutairi M, Gopal K, Greenwell AA, et al. The GLP-1 receptor agonist liraglutide increases myocardial glucose oxidation rates via indirect mechanisms and mitigates experimental diabetic cardiomyopathy. Can J Cardiol. 2020;08:e1016.
   Google Scholar
• Fan S, Xiong Q, Zhang X, et al. Glucagon-like peptide 1 reverses myocardial hypertrophy through cAMP/PKA/RhoA/ROCK2 signaling. Acta Biochim Biophys Sin. 2020;52(6):612–619.
   Google Scholar
• Herrera Comoglio R, Vidal Guitart X. Cardiovascular outcomes, heart failure and mortality in type 2 diabetic patients treated with glucagon-like peptide 1 receptor agonists (GLP-1 RAs): a systematic review and meta-analysis of observational cohort studies. Int J Clin Pract. 2020;74(9):e13553.
   PubMed Web of Science ®Google Scholar
• Bjornholm KD, Skovsted GF, Mitgaard-Thomsen A, et al. Liraglutide treatment improves endothelial function in the Ldlr-/- mouse model of atherosclerosis, and affects genes involved in vascular remodelling and inflammation. Basic Clin Pharmacol Toxicol. 2020;9:e12386.
   Google Scholar
• Fan SH, Xiong QF, Wang L, et al. Glucagon-like peptide 1 treatment reverses vascular remodelling by downregulating matrix metalloproteinase 1 expression through inhibition of the ERK1/2/NF-kappaB signalling pathway. Mol Cell Endocrinol. 2020;518:111005.
   PubMed Web of Science ®Google Scholar
• Zhou H, Tu Q, Zhang Y, et al. Shear stress improves the endothelial progenitor cell function via the CXCR7/ERK pathway axis in the coronary artery disease cases. BMC Cardiovasc Disord. 2020;20(1):403.
   PubMed Web of Science ®Google Scholar
• Chai M, Gu C, Shen Q, et al. Hypoxia alleviates dexamethasone-induced inhibition of angiogenesis in cocultures of HUVECs and rBMSCs via HIF-1α. Stem Cell Res Ther. 2020;11(1):343.
   PubMed Web of Science ®Google Scholar
• Zhu H, Zhao M, Chen Y, et al. Bcl-2-associated athanogene 5 overexpression attenuates catecholamine-induced vascular endothelial cell apoptosis. J Cell Physiol. 2020;7:e2994.
   Google Scholar
• Deng Z, Zhou L, Wang Y, et al. Astrocyte-derived VEGF increases cerebral microvascular permeability under high salt conditions. Aging. 2020;12(12):11781–11793.
   PubMedGoogle Scholar
• Afonso CB, Spickett CM. Lipoproteins as targets and markers of lipoxidation. Redox Biol. 2019;23:101066.
   PubMed Web of Science ®Google Scholar
• Affinito A, Quintavalle C, Esposito CL, et al. The discovery of RNA aptamers that selectively bind glioblastoma stem cells. Mol Ther Nucleic Acids. 2019;18:99–109.
   PubMedGoogle Scholar
• Guo C, He J, Song X, et al. Pharmacological properties and derivatives of shikonin-A review in recent years. Pharmacol Res. 2019;149:104463.
   PubMed Web of Science ®Google Scholar
• Kan X, Liu B, Guo W, et al. Myricetin relieves LPS-induced mastitis by inhibiting inflammatory response and repairing the blood-milk barrier. J Cell Physiol. 2019;234(9):16252–16262.
   Web of Science ®Google Scholar
• Feng W, Gong H, Wang Y, et al. circIFT80 functions as a ceRNA of miR-1236-3p to promote colorectal cancer progression. Mol Ther Nucleic Acids. 2019;18:375–387.
   PubMedGoogle Scholar
• Morton AB, Smuder AJ, Wiggs MP, et al. Increased SOD2 in the diaphragm contributes to exercise-induced protection against ventilator-induced diaphragm dysfunction. Redox Biol. 2019;20:402–413.
   PubMed Web of Science ®Google Scholar
• Lan YL, Zou YJ, Lou JC, et al. The sodium pump α1 subunit regulates bufalin sensitivity of human glioblastoma cells through the p53 signaling pathway. Cell Biol Toxicol. 2019;35(6):521–539.
   PubMed Web of Science ®Google Scholar
• Lu HY, Zu YX, Jiang XW, et al. Novel ADAM-17 inhibitor ZLDI-8 inhibits the proliferation and metastasis of chemo-resistant non-small-cell lung cancer by reversing Notch and epithelial mesenchymal transition in vitro and in vivo. Pharmacol Res. 2019;148:104406.
   PubMed Web of Science ®Google Scholar
• Luo W, Chen J, Li L, et al. c-Myc inhibits myoblast differentiation and promotes myoblast proliferation and muscle fibre hypertrophy by regulating the expression of its target genes, miRNAs and lincRNAs. Cell Death Differ. 2019;26(3):426–442.
   PubMed Web of Science ®Google Scholar
• Sim WC, Kim DG, Lee W, et al. Activation of SIRT1 by L-serine increases fatty acid oxidation and reverses insulin resistance in C2C12 myotubes (L-serine activates SIRT1 in C2C12 myotubes). Cell Biol Toxicol. 2019;35(5):457–470.
   PubMed Web of Science ®Google Scholar
• Paolini E, Stronati G, Guerra F, et al. Flecainide: electrophysiological properties, clinical indications, and practical aspects. Pharmacol Res. 2019;148:104443.
   PubMed Web of Science ®Google Scholar
• Li X, Tian Y, Tu MJ, et al. Bioengineered miR-27b-3p and miR-328-3p modulate drug metabolism and disposition via the regulation of target ADME gene expression. Acta Pharm Sin B. 2019;9(3):639–647.
   PubMed Web of Science ®Google Scholar
• Dos Santos PK, Altei WF, Danilucci TM, et al. Alternagin-C (ALT-C), a disintegrin-like protein, attenuates alpha2beta1 integrin and VEGF receptor 2 signaling resulting in angiogenesis inhibition. Biochimie. 2020;174:144–158.
   PubMed Web of Science ®Google Scholar
• Qiu T, Zhou H, Li S, et al. Effects of Saccharides from Arctium lappa L. root on FeCl3-induced arterial thrombosis via the ERK/NF-κB signaling pathway. Oxid Med Cell Longev. 2020;2020:7691352.
   PubMed Web of Science ®Google Scholar
• Shi C, Li Z, Wu Y, et al. Euscaphic acid and tormentic acid protect vascular endothelial cells against hypoxia-induced apoptosis via PI3K/AKT or ERK 1/2 signaling pathway. Life Sci. 2020;252:117666.
   PubMed Web of Science ®Google Scholar
• Luan Y, Zhang J, Wang M, et al. Advanced glycation end products facilitate the proliferation and reduce early apoptosis of cardiac microvascular endothelial cells via PKCβ signaling pathway: insight from diabetic cardiomyopathy. Anatol J Cardiol. 2020;23(3):141–150.
   PubMed Web of Science ®Google Scholar
• Xu S. Therapeutic potential of blood flow mimetic compounds in preventing endothelial dysfunction and atherosclerosis. Pharmacol Res. 2020;155:104737.
   PubMed Web of Science ®Google Scholar
• Le Y, Wei R, Yang K, et al. Liraglutide ameliorates palmitate-induced oxidative injury in islet microvascular endothelial cells through GLP-1 receptor/PKA and GTPCH1/eNOS signaling pathways. Peptides. 2020;124:170212.
   PubMed Web of Science ®Google Scholar